首页> 外文期刊>European Journal of Cancer Supplements >Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study
【24h】

Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study

机译:电化学疗法-一种简便,高效,安全的皮肤和皮下转移治疗方法:ESOPE(欧洲标准电化学疗法操作程序)研究结果

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To evaluate and confirm efficacy and safety of electrochemotherapy with bleomy-cin or cisplatin on cutaneous and subcutaneous tumour nodules of patients with malignant melanoma and other malignancies in a multicenter study. Patients and methods: This was a two year long prospective non-randomised study on 41 patients evaluable for response to treatment and 61 evaluable for toxicity. Four cancer centers enrolled patients with progressive cutaneous and subcutaneous metastases of any histologically proven cancer. The skin lesions were treated by electrochemotherapy, using application of electric pulses to the tumours for increased bleomycin or cisplatin delivery into tumour cells. The treatment was performed using intravenous or intratumoural drug injection, followed by application of electric pulses generated by a Cliniporator~(TM) using plate or needle electrodes. Tumour response to electrochemotherapy as well as possible side-effects with respect to the treatment approach, tumour histology andlocation of the tumour nodules and electrode type were evaluated. Results: An objective response rate of 85% (73.7% complete response rate) was achieved on the electrochemotherapy treated tumour nodules, regardless of tumour histology, and drug used or route of its administration. At 150 days after the treatment (median follow up was 133 days and range 60-380 days) local tumour control rate for electrochemotherapy was 88% with bleomycin given intravenously, 73% with bleomycin given intratumourally and 75% with cisplatin given intratumourally, demonstrating that all three approaches were similarly effective in local tumour treatment. Furthermore, electrochemotherapy was equally effective regardless of the tumour type and size of the nodules treated. Side-effects of electrochemotherapy were minor and acceptable, as reported by the patients. Conclusion: We demonstrated that electrochemotherapy is an easy, highly effective, safe and cost-effective approach for the treatment of cutaneous and subcutaneous tumour nodules of different malignancies. Electrochemotherapy can provide immediate clinical benefit in patients with advanced cutaneous and subcutaneous metastases.
机译:目的:在一项多中心研究中,评估并确认博莱霉素或顺铂电化学疗法对恶性黑色素瘤和其他恶性肿瘤患者的皮肤和皮下肿瘤结节的有效性和安全性。患者和方法:这是一项为期两年的前瞻性非随机研究,对41例患者的治疗反应和61例毒性进行了评估。四个癌症中心招募了具有任何经组织学证实的癌症进行性皮肤和皮下转移的患者。皮肤病变通过化学疗法进行治疗,使用电脉冲对肿瘤进行治疗,以增加博来霉素或顺铂向肿瘤细胞的递送。使用静脉内或肿瘤内药物注射进行治疗,然后使用板状或针状电极施加由CliniporatorTM产生的电脉冲。评估了对电化学疗法的肿瘤反应以及在治疗方法,肿瘤组织学,肿瘤结节的位置和电极类型方面可能产生的副作用。结果:不论肿瘤的组织学,所用药物或给药途径如何,经电疗治疗的肿瘤结节的客观缓解率均达到85%(完全缓解率达到73.7%)。治疗后150天(中位随访时间为133天,范围为60-380天),电化学治疗的局部肿瘤控制率是博莱霉素静脉注射88%,博莱霉素瘤内注射73%和顺铂75%肿瘤内注射。这三种方法在局部肿瘤治疗中均具有相似的效果。此外,无论肿瘤类型和所治疗结节的大小如何,电化学疗法均有效。根据患者的报道,电化学疗法的副作用很小并且可以接受。结论:我们证明了电化学疗法是一种治疗不同恶性肿瘤的皮肤和皮下肿瘤结节的简便,高效,安全且具有成本效益的方法。电化学疗法可以为晚期皮肤和皮下转移患者提供直接的临床益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号